West Pharmaceutical Services shares owned by Conestoga Capital Advisors
Quarter-by-quarter ownership of West Pharmaceutical Services (WST) shares owned by Conestoga Capital Advisors
from 13F filings
Historical chart of Conestoga Capital Advisors investment in West Pharmaceutical Services
Tip: Access up to 7 years of quarterly data
All positions including West Pharmaceutical Services held by Conestoga Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in West Pharmaceutical Services by Conestoga Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $26M | 101k | 262.33 |
| 2025-06-30 | $24M | 108k | 218.80 |
| 2025-03-31 | $16M | 72k | 223.88 |
| 2024-12-31 | $22M | 67k | 327.56 |
| 2024-09-30 | $13M | 42k | 300.16 |
| 2024-06-30 | $14M | 42k | 329.39 |
| 2024-03-31 | $14M | 36k | 395.71 |
| 2023-12-31 | $20M | 55k | 352.12 |
| 2023-09-30 | $21M | 56k | 375.21 |
| 2023-06-30 | $22M | 58k | 382.47 |
| 2023-03-31 | $21M | 62k | 346.47 |
| 2022-12-31 | $14M | 61k | 235.35 |
| 2022-09-30 | $15M | 60k | 246.08 |
| 2022-06-30 | $18M | 59k | 302.38 |
| 2022-03-31 | $30M | 72k | 410.71 |
| 2021-12-31 | $34M | 72k | 469.01 |
| 2021-09-30 | $37M | 87k | 424.53 |
| 2021-06-30 | $36M | 101k | 359.10 |
| 2021-03-31 | $28M | 98k | 281.78 |
| 2020-12-31 | $27M | 95k | 283.31 |
| 2020-09-30 | $25M | 90k | 274.90 |
| 2020-06-30 | $18M | 78k | 227.17 |
| 2020-03-31 | $12M | 82k | 152.25 |
| 2019-12-31 | $6.0M | 40k | 150.33 |
| 2019-09-30 | $5.5M | 39k | 141.83 |
| 2019-06-30 | $5.0M | 40k | 125.14 |
| 2019-03-31 | $4.3M | 39k | 110.20 |
| 2018-12-31 | $3.2M | 33k | 98.04 |
| 2018-09-30 | $4.1M | 34k | 123.48 |
| 2018-06-30 | $2.7M | 28k | 99.28 |
| 2018-03-31 | $2.3M | 26k | 88.30 |
| 2017-12-31 | $2.1M | 21k | 98.65 |
| 2017-09-30 | $2.5M | 26k | 96.26 |
| 2017-06-30 | $1.1M | 12k | 94.52 |
| 2017-03-31 | $908k | 11k | 81.62 |
More positions owned by Conestoga Capital Advisors
View all positions for Conestoga Capital Advisors